Aaron Zhang

Aaron Zhang is an accomplished finance professional with extensive experience in private equity and investment banking. Since 2012, Aaron has served as a Director at The Carlyle Group, focusing on healthcare investments. Additionally, Aaron holds board member positions at Shanghai BiOligo Biotech and AmbioPharm, both of which have been active since 2021 and 2019, respectively. Previously, Aaron worked as an Associate at Goldman Sachs from 2010 to 2012, specializing in TMT and natural resources, and as a Senior Manager at The Parthenon Group, where Aaron was a founding member of the China Practice from 2007 to 2008. Aaron holds an MBA in Finance and Entrepreneurship from The University of Chicago Booth School of Business and a Bachelor of Economics from Fudan University.